TNF-alpha gene polymorphisms in Iranian Azari Turkish patients with inflammatory bowel diseases. 2014

Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
Liver and Gastrointestinal Disease Research Centre of Tabriz University of Medical Sciences, Tabriz, Iran.

BACKGROUND Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the bowel (IBD) whose causes are not fully known. Emerging data indicate that alterations in cytokine synthesis may play a role in IBD pathogenesis. OBJECTIVE We aimed to determine the association between tumor necrosis factor-alfa (TNFα) promoter polymorphisms (at positions - 308 and - 1031) and susceptibility to IBD among Iranian Azari Turkish patients. METHODS One hundred and one patients with IBD and 100 healthy subjects were analyzed. METHODS Both polymorphisms in the promoter region of the TNFα gene at positions -1031T/C and -308G/A were detected by polymerase chain reaction-restriction fragment length polymorphism assay. All statistical analyses were calculated with SPSS for Windows 16.0. The Fisher's exact test was used to test for departure from Hardy-Weinberg equilibrium of the genotype frequencies (P > 0.05). RESULTS The allele frequency of the TNFα-308G and -1031T were higher in IBD patients but did not reach statistical significance. However, the homozygous TT genotype for the SNP-1031 T > C was significantly higher in UC patients than in healthy controls (P = 0.01) and the heterozygous CT genotype for the SNP -1031 T > C was significantly lower in UC patients than in healthy controls (P = 0.03). CONCLUSIONS The TNFα-1031 T allele confers a significant risk for developing UC in Iranian Azeri Turkish patients. Also the frequency of TNFα-1031 C allele was considerably low among patients with UC and it may have protective role among them (OR = 0.43; P = 0.01).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
December 2009, Rheumatology international,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
May 2006, Scandinavian journal of gastroenterology,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
June 2016, Turkish journal of medical sciences,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
March 2007, Acta neurologica Scandinavica,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
January 2020, Annals of human genetics,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
December 2008, Journal of gastroenterology and hepatology,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
January 2017, Journal of infection and public health,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
January 2015, Turkish journal of medical sciences,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
January 2014, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association,
Mortaza Bonyadi, and Reza Abdolmohammadi, and Zohreh Jahanafrooz, and Mohammad-Hosein Somy, and Manoochehr Khoshbaten
April 2006, Journal of gastroenterology,
Copied contents to your clipboard!